NEURX DIAPHRAGM PACING SYSTEM 20-0035

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2013-10-08 for NEURX DIAPHRAGM PACING SYSTEM 20-0035 manufactured by Synapse Biomedical Inc..

Event Text Entries

[3775242] The pt was implanted with the device sometime around (b)(6) 2012. The pt also received an intercostal nerve transfer and was unable to use the device until complete recovery from the transfer, about march of 2013 the pt began using the device for approx 8 hours per day. About (b)(6) 2013, the pt complained of feeling the diaphragm pacing "in his heart". The physician has confirmed the pt did not experience vtach with stimulation from the device. Stimulation settings were reduced and the symptoms resolved. On (b)(6) 2013, the physician surgically replaced the electrode that were the source of the stimulation associated with the arrythmia. The pt has resumed using the device without further incident.
Patient Sequence No: 1, Text Type: D, B5


[11153634] Synapse biomedical was not informed that this pt had been implanted until the initiating incident was reported approx one year after implantation. It was first reported that the pt needed a repair and replacement of electrode leads to relieve pain "in his heart" experienced with stimulation. Assistance from synapse was requested for the repair procedure. Over a period of two months following the procedure, synapse learned that the pt had received an intercostal nerve transfer sometime around the time the synapse device was implanted. Eventually synapse also learned that, in addition to pain, the pt has experienced ventricular tachycardia. Because of the recent (at the time of device implantation) nerve transfer the device was not tested for a cardiac capture per the procedures identified in the surgical instructions for use. Therefore, it went undetected that some of the electrodes were placed in a position that could cause cardiac rhythm interference. The implanting/reporting physician recognizes that, due to the unusual circumstance of a nerve transfer, the tp was not properly tested according to procedures identified in the product labeling at the time of device implantation. This physician is trained and experienced in use of the device and the testing was not overlooked but could not be properly performed due to the nerve transfer. However, the testing should have been performed later, prior to first use of the device. No device defect or malfunction was indicated. Deviation from established procedures due to unusual circumstances appear to be the sole contributing factor.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005868392-2013-00001
MDR Report Key3410448
Report Source05
Date Received2013-10-08
Date of Report2013-10-07
Date of Event2013-05-10
Date Mfgr Received2013-07-22
Device Manufacturer Date2012-02-09
Date Added to Maude2013-11-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional0
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMARK BARBUTES, DIR.
Manufacturer Street300 ARTINO STREET
Manufacturer CityOBERLIN OH 44074
Manufacturer CountryUS
Manufacturer Postal44074
Single Use0
Remedial ActionMA
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEURX DIAPHRAGM PACING SYSTEM
Generic NameOIR DIAPHGRAGMATIC/PHRENIC NERVE LAPAROS
Product CodeHCC
Date Received2013-10-08
Model Number20-0035
Lot Number20-0035-020912-7-1
Device Expiration Date2013-11-30
OperatorLAY USER/PATIENT
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSYNAPSE BIOMEDICAL INC.
Manufacturer AddressOBERLIN OH US


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening; 2. Required No Informationntervention 2013-10-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.